3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Recurrent Platinum Resistant Ovarian Cancer
1
Rectal Neoplasms
1
Neoplasm Metastasis
1
Colorectal Neoplasms
1
Carcinoma
1
Adenoviridae Infections
1
Interventions
Fluorouracil
38
Capecitabine
31
Oxaliplatin
30
Leucovorin
30
Radiotherapy
21
Irinotecan
20
Bevacizumab
15
Radiation
12
Cetuximab
12
pembrolizumab
9
Gemcitabine
7
trifluridine tipiracil drug combination
5
dehydroftorafur
5
cediranib
5
Radiotherapy, Intensity-Modulated
5
Folfox protocol
5
Erlotinib Hydrochloride
5
Cisplatin
5
Carboplatin
5
trametinib
4
Surgical Procedures, Operative
4
Paclitaxel
4
Neoadjuvant Therapy
4
Gene Expression Profiling
4
Cyclophosphamide
4
sargramostim
3
binimetinib
3
Trifluridine
3
Sorafenib
3
Pemetrexed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Rectal Neoplasms
×
enadenotucirev
×
Clear all
NCT03916510
2025-02-06
CEDAR
University of Oxford
Phase 1
Completed
12 enrolled
13 charts